NeXeption, Not The Rule: Another Twist On Asset-Based Financing
This article was originally published in Start Up
Executive Summary
As VCs experiment with new models for single-asset companies, new entrant NeXeption is trying something similar without raising its own fund. Can it wring enough value from the best assets pharmas are neglecting, without giving too much back to their original owners?